Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ECTE > SEC Filings for ECTE > Form 8-K on 7-Jun-2013All Recent SEC Filings

Show all filings for ECHO THERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro



Other Events, Financial Statements and Exhibits

Item 8.01. Other Information.

Reverse Stock Split

On June 7, 2013, Echo Therapeutics, Inc. (the "Company") filed an Amendment to the Company's Certificate of Incorporation with the Delaware Secretary of State to effect a 1-for-10 reverse stock split of the Company's common stock, which was effective at approximately 8 a.m. on June 7, 2013. As a result of the reverse stock split, every ten shares of the Company's issued and outstanding common stock will be combined into one share of common stock and any fractional shares created by the reverse stock split will be rounded up to the nearest whole share.

The reverse stock split applies to the issuance of the Company's common stock pursuant to stock options, restricted stock, convertible preferred stock, and warrants outstanding immediately prior to the effective date of the reverse stock split. The reverse stock split will reduce the number of shares of the Company's common stock outstanding from 60,535,169 shares on June 6, 2013 to approximately 6,053,517 shares.

Each shareholder's percentage ownership interest in the Company and the proportional voting power remain unchanged after the reverse stock split, except for minor changes and adjustments resulting from rounding of fractional interest. The rights and privileges of the holders of the Company's common stock are unaffected by the reverse stock split.

Beginning with the opening of trading on June 7, 2013, the Company's common stock will trade on the NASDAQ Capital Market on a split-adjusted basis. The Amendment to the Company's Certificate of Incorporation is filed as Exhibit 3.1 hereto.

Corporate Presentation at Jefferies 2013 Global Healthcare Conference

On June 6, 2013, Patrick Mooney, M.D., the Company's President and Chief Executive Officer, presented at the Jefferies 2013 Global Healthcare Conference. A copy of the presentation is attached as Exhibit 99.1 to this report.

Item 9.01. Financial Statements and Exhibits.

On June 6, 2013, the Company issued a press release regarding the reverse stock split. A copy of the press release is attached as Exhibit 99.2 to this report.

The Exhibits listed in the Exhibit Index immediately preceding such Exhibits are filed with or incorporated by reference in this report.

  Add ECTE to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ECTE - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.